loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 205755 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Novartis Pharmaceuticals Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NOVARTIS (1)

    filter

    01 CAPSULE;ORAL (1)

    filter

    01 DISCN (1)

    filter

    01 ZYKADIA (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CERITINIB

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE; ORAL
    150MG
    2014-04-29
    205755
    ZYKADIA
    DISCN
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 205755

    Looking for FDA Orange Book APPLICATION 205755 1

    19

    Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is CERITINIB, with a corresponding application number 205755.

    Regulatory Information DISCN

    With a dosage strength 150MG

    Dosage Form Route CAPSULE; ORAL

    Reference Listed Drug Yes

    Approved since 2014-04-29

    Post Enquiry
    POST ENQUIRY